Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals is an emerging biotechnology company engaged in the development of novel therapeutics to treat unmet medical needs to improve women’s health. It has developed a pipeline of drug candidates for the treatment of unmet needs in women’s cancers by acquiring a novel portfolio of anticancer drugs targeting a novel mechanism to treat gynecological and triple-negative breast cancers. The Company will treat gynecological disturbances by repurposing approved drugs with proprietary technologies to create a pipeline of novel therapeutics. The company has developed an accelerated time to market strategy to enable commercializing the first of many new therapies by 2019.